Form 4: Cryoport CSO Sells Shares for Tax Obligations

Cryoport's Chief Scientific Officer, Mark W. Sawicki, sold 1,341 shares of common stock to cover tax obligations related to restricted stock vesting.

Summary

• Mark W. Sawicki, Chief Scientific Officer of Cryoport, Inc. (CYRX), reported a sale of common stock.
• The transaction involved the disposition of 1,341 shares of Cryoport common stock.
• The shares were sold at a price of $8.18 per share.
• The sale was executed on March 23, 2026.
• The purpose of the sale was to cover tax obligations arising from the vesting of restricted stock rights, in accordance with the Issuer's policies.
• Following this transaction, Mark W. Sawicki beneficially owns 102,356 shares of Cryoport common stock directly.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. While it's an insider sale, the explicit reason for tax obligations on restricted stock vesting makes it a non-discretionary, routine event, which typically does not signal negative sentiment from the insider.

Negatives

• A reduction in direct insider ownership by 1,341 shares, although for a non-discretionary tax purpose.

Future Outlook

No forward-looking statements or guidance were provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that insider sales for tax obligations upon the vesting of restricted stock are a common and routine occurrence for executives in publicly traded companies. Such transactions are generally not interpreted as a reflection of management's sentiment regarding the company's future performance or stock valuation, unlike discretionary sales.

Corporate Governance

Stakeholder Impact

• Shareholders: A minor reduction in direct insider ownership, but the non-discretionary nature of the sale mitigates concerns about management's confidence.

Key Dates

Recommendation

The sale by Cryoport's Chief Scientific Officer was a non-discretionary transaction to cover tax obligations from restricted stock vesting, which is a routine event and does not reflect a change in the company's fundamentals or management's long-term outlook. Therefore, a 'hold' recommendation is appropriate as this event does not provide new information to alter an existing investment thesis.

Keywords

Cryoport, CYRX, Insider Transaction, Form 4, Stock Sale, Chief Scientific Officer, Mark Sawicki, Restricted Stock, Tax Obligations